Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2010

01-04-2010 | Case Report

Focal segmental glomerulosclerosis in a patient with isolated ACTH deficiency and reversible hypothyroidism

Authors: Shunsuke Yamada, Sachiko Bandai, Kohsuke Masutani, Akihiro Tsuchimoto, Hideko Noguchi, Mikio Munakata, Kazuhiko Tsuruya, Mitsuo Iida

Published in: Clinical and Experimental Nephrology | Issue 2/2010

Login to get access

Abstract

A 23-year-old man was admitted to our hospital for fatigue, anorexia, proteinuria, and peripheral edema. Proteinuria was first pointed out at the age of 15, but no further studies were performed. Six years prior to admission, the patient noted becoming easily fatigued. Laboratory tests on admission showed marked peripheral eosinophilia (29.2%, count: 1,071/μL) and proteinuria. Endocrinological studies revealed isolated adrenocorticotropic hormone deficiency with primary hypothyroidism, but a lack of autoimmune thyroiditis. Renal biopsy showed focal segmental glomerulosclerosis. Hydrocortisone therapy (30 mg/day) for isolated adrenocorticotropic hormone deficiency resulted in marked improvement of adrenal and thyroid functions, and amelioration of proteinuria (from 2.8 to 1.0 g/day) over a two-month period. Renal function remains normal at five years after the start of hydrocortisone treatment. The findings suggest that both hydrocortisone therapy and normalized thyroid hormone status played a pivotal role in the improvement of proteinuria associated with focal segmental glomerulosclerosis.
Literature
1.
go back to reference Ferrario F, Rastaldi MP, Pasi A. Secondary focal and segmental glomerulosclerosis. Nephrol Dial Transplant. 1999;14:58–67.CrossRefPubMed Ferrario F, Rastaldi MP, Pasi A. Secondary focal and segmental glomerulosclerosis. Nephrol Dial Transplant. 1999;14:58–67.CrossRefPubMed
2.
go back to reference Reidy K, Kaskel FJ. Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol. 2007;22:350–4.CrossRefPubMed Reidy K, Kaskel FJ. Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol. 2007;22:350–4.CrossRefPubMed
3.
go back to reference Fukasawa H, Kato A, Suzuki H, et al. Focal segmental glomerulosclerosis in a case of panhypopituitarism: a possible role of growth hormone treatment. Clin Nephrol. 2002;58:317–20.PubMed Fukasawa H, Kato A, Suzuki H, et al. Focal segmental glomerulosclerosis in a case of panhypopituitarism: a possible role of growth hormone treatment. Clin Nephrol. 2002;58:317–20.PubMed
4.
go back to reference Takai M, Izumino K, Oda Y, et al. Focal segmental glomerulosclerosis associated with acromegaly. Clin Nephrol. 2007;56:75–7. Takai M, Izumino K, Oda Y, et al. Focal segmental glomerulosclerosis associated with acromegaly. Clin Nephrol. 2007;56:75–7.
5.
go back to reference Yoshida H, Akikusa B, Saeki N, et al. Effect of pituitary microsurgery on acromegaly complicated nephrotic syndrome with focal segmental glomerulosclerosis: report of a rare clinical case. Am J Kidney Dis. 1999;33:1158–63.CrossRefPubMed Yoshida H, Akikusa B, Saeki N, et al. Effect of pituitary microsurgery on acromegaly complicated nephrotic syndrome with focal segmental glomerulosclerosis: report of a rare clinical case. Am J Kidney Dis. 1999;33:1158–63.CrossRefPubMed
7.
go back to reference Yamamoto T, Fukuyama J, Hasegawa K, et al. Isolated adrenocorticotropin deficiency in adults. Report of 10 cases and review of literature. Arch Intern Med. 1992;152:1705–12.CrossRefPubMed Yamamoto T, Fukuyama J, Hasegawa K, et al. Isolated adrenocorticotropin deficiency in adults. Report of 10 cases and review of literature. Arch Intern Med. 1992;152:1705–12.CrossRefPubMed
8.
go back to reference Arrizabalaga P, Bergada E, Sole M, et al. Focal segmental glomerular sclerosis in two patients with Addison’s disease: any more than fortuitous development of glomerular disease? Am J Nephrol. 2002;22:389–93.CrossRefPubMed Arrizabalaga P, Bergada E, Sole M, et al. Focal segmental glomerular sclerosis in two patients with Addison’s disease: any more than fortuitous development of glomerular disease? Am J Nephrol. 2002;22:389–93.CrossRefPubMed
9.
go back to reference Hsieh CK, Hsieh YP, Wen YK, et al. Focal segmental glomerulosclerosis in association with Cushing’s disease. Clin Nephrol. 2007;67:109–13.PubMed Hsieh CK, Hsieh YP, Wen YK, et al. Focal segmental glomerulosclerosis in association with Cushing’s disease. Clin Nephrol. 2007;67:109–13.PubMed
10.
go back to reference Warady BA, Howard CP, Hellerstein S, et al. Congenital nephrosis in association with hypothyroidism and adrenocorticism. Pediatr Nephrol. 1993;7:79–80.CrossRefPubMed Warady BA, Howard CP, Hellerstein S, et al. Congenital nephrosis in association with hypothyroidism and adrenocorticism. Pediatr Nephrol. 1993;7:79–80.CrossRefPubMed
11.
12.
go back to reference Salmon MI, Scala VD, Grishman E, et al. Renal lesions in hypothyroidism: a study based on kidney biopsies. Metabolism. 1967;16:54–9. Salmon MI, Scala VD, Grishman E, et al. Renal lesions in hypothyroidism: a study based on kidney biopsies. Metabolism. 1967;16:54–9.
13.
go back to reference Enriquez R, Sirvent AE, Amoros F, et al. IgA nephropathy and autoimmune thyroid disease. Clin Nephrol. 2002;57:406–7.PubMed Enriquez R, Sirvent AE, Amoros F, et al. IgA nephropathy and autoimmune thyroid disease. Clin Nephrol. 2002;57:406–7.PubMed
14.
go back to reference Mooraki A, Broumand B, Neekdoost F, et al. Reversible acute renal failure with hypothyroidism: report of four cases with a brief review of literature. Nephrology (Carlton). 2003;8:57–60.CrossRef Mooraki A, Broumand B, Neekdoost F, et al. Reversible acute renal failure with hypothyroidism: report of four cases with a brief review of literature. Nephrology (Carlton). 2003;8:57–60.CrossRef
15.
go back to reference Weetman AP, Pinchinq AJ, Pussel BA, et al. Membranous glomerulonephritis and autoimmune thyroid disease. Clin Nephrol. 1981;15:50–1.PubMed Weetman AP, Pinchinq AJ, Pussel BA, et al. Membranous glomerulonephritis and autoimmune thyroid disease. Clin Nephrol. 1981;15:50–1.PubMed
16.
go back to reference Saito T, Tojo K, Yamamoto H, et al. Isolated adrenocorticotropin deficiency presenting with impaired rennin-angiotensin-aldosterone system and suppressed parathyroid hormone-vitamin D axis. Internal Med. 2002;41:561–5.CrossRef Saito T, Tojo K, Yamamoto H, et al. Isolated adrenocorticotropin deficiency presenting with impaired rennin-angiotensin-aldosterone system and suppressed parathyroid hormone-vitamin D axis. Internal Med. 2002;41:561–5.CrossRef
17.
go back to reference Shigemasa C, Kouchi T, Ueta Y, et al. Evaluation of thyroid function in patients with isolated adrenocorticotropin deficiency. Am J Med Sci. 1992;304:279–84.CrossRefPubMed Shigemasa C, Kouchi T, Ueta Y, et al. Evaluation of thyroid function in patients with isolated adrenocorticotropin deficiency. Am J Med Sci. 1992;304:279–84.CrossRefPubMed
18.
go back to reference Tamura M, Yokoyama N, Nishikawa T, et al. Improvement of hypothyroidism after glucocorticoid replacement in isolated adrenocorticotropin deficiency. Internal Med. 1995;34:559–63.CrossRef Tamura M, Yokoyama N, Nishikawa T, et al. Improvement of hypothyroidism after glucocorticoid replacement in isolated adrenocorticotropin deficiency. Internal Med. 1995;34:559–63.CrossRef
Metadata
Title
Focal segmental glomerulosclerosis in a patient with isolated ACTH deficiency and reversible hypothyroidism
Authors
Shunsuke Yamada
Sachiko Bandai
Kohsuke Masutani
Akihiro Tsuchimoto
Hideko Noguchi
Mikio Munakata
Kazuhiko Tsuruya
Mitsuo Iida
Publication date
01-04-2010
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2010
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-009-0228-9

Other articles of this Issue 2/2010

Clinical and Experimental Nephrology 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.